- Home
- FMST vs VNRX Comparison
FMST vs VNRX Comparison
Compare FMST & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMST | VNRX |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 31.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FMST | VNRX |
|---|---|---|
| Price | $1.92 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 300.4K | ★ 2.2M |
| Earning Date | 02-21-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $0.55 | $0.22 |
| 52 Week High | $5.74 | $0.94 |
Technical Indicators
Market Signals| Indicator | FMST | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.18 | 49.67 |
| Support Level | $2.09 | $0.25 |
| Resistance Level | $2.79 | $0.29 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 3.36 | 35.60 |
Price Performance
Historical ComparisonAbout FMST Foremost Lithium Resource & Technology Ltd.
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.